TabletsTablets
Over-The-Counter (OTC)Nutraceuticals & AntioxidantsCode: 939

Levocarnitine Tablets 500mg

Generic Formulation:Levocarnitine Tablets 500mg
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹52.5
Brand Estimate*
₹438.03
Estimated Savings:₹385.53 (88% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Levocarnitine Tablets (500mg) and Injection (1g) is an oral and parenteral carrier molecule on the WHO Model List of Essential Medicines. It facilitates the transport of long-chain fatty acids across the inner mitochondrial membrane via carnitine palmitoyltransferase (CPT-1) for beta-oxidation and cellular energy synthesis, and removes toxic intracellular acyl compounds. Indicated for primary and secondary carnitine deficiency in end-stage renal disease (ESRD) patients on hemodialysis, metabolic organic acidurias, and valproic acid-induced hyperammonemic hepatotoxicity.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 939.Report inaccuracy

Usage Guidelines

Tablets: Take orally 500 mg two to three times daily with meals with water. Injection: Administer by slow IV push (over 2-3 minutes) at the end of each hemodialysis session (typically 1 to 2 g).

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Nausea, vomiting, diarrhea, abdominal cramps, fishy body odor (due to gut bacterial conversion to trimethylamine).

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Over-The-Counter / Prescription metabolic nutrient. Use only L-carnitine (D-carnitine is an antagonist causing myasthenia). Dialysis patients benefit from IV administration at the end of dialysis.

Medical Disclaimer: Statutory Nutritional & Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice or clinical dietetic guidance. Dietary supplements, micronutrients, parenteral electrolytes, and specialized clinical nutrition should be used under the supervision of a registered medical practitioner or clinical nutritionist.